These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 21817084)

  • 41. In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii.
    Ni W; Cui J; Liang B; Cai Y; Bai N; Cai X; Wang R
    J Antibiot (Tokyo); 2013 Dec; 66(12):705-8. PubMed ID: 23981963
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Meta-analysis of colistin for the treatment of Acinetobacter baumannii infection.
    Chen Z; Chen Y; Fang Y; Wang X; Chen Y; Qi Q; Huang F; Xiao X
    Sci Rep; 2015 Nov; 5():17091. PubMed ID: 26597507
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii.
    García-Quintanilla M; Carretero-Ledesma M; Moreno-Martínez P; Martín-Peña R; Pachón J; McConnell MJ
    Int J Antimicrob Agents; 2015 Dec; 46(6):696-702. PubMed ID: 26391380
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii.
    Bae S; Kim MC; Park SJ; Kim HS; Sung H; Kim MN; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS; Chong YP
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6774-6779. PubMed ID: 27600048
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tolerability and efficacy of long-term treatment with daptomycin, ceftazidime and colistin in a patient with a polymicrobial, multidrug-resistant prosthetic joint reinfection: a case report.
    Pasticci MB; Di Filippo P; Pasqualini L; Mencacci A; Pallotto C; Malincarne L; Baldelli F
    J Med Case Rep; 2014 Jun; 8():186. PubMed ID: 24923703
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rifampicin as adjunct to colistin therapy in the treatment of multidrug-resistant Acinetobacter baumannii.
    Al-Shaer M; Nazer LH; Kherallah M
    Ann Pharmacother; 2014 Jun; 48(6):766-71. PubMed ID: 24651164
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Editorial commentary: rifampicin plus colistin in the era of extensively drug-resistant Acinetobacter baumannii infections.
    Gauthier TP
    Clin Infect Dis; 2013 Aug; 57(3):359-61. PubMed ID: 23616496
    [No Abstract]   [Full Text] [Related]  

  • 48. Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infections.
    Gounden R; Bamford C; van Zyl-Smit R; Cohen K; Maartens G
    BMC Infect Dis; 2009 Mar; 9():26. PubMed ID: 19272139
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Colistin and rifampicin combination in the treatment of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
    Song JY; Lee J; Heo JY; Noh JY; Kim WJ; Cheong HJ; Hwang IS
    Int J Antimicrob Agents; 2008 Sep; 32(3):281-4. PubMed ID: 18650070
    [No Abstract]   [Full Text] [Related]  

  • 51. Successful treatment of meningitis caused by multidrug-resistant Acinetobacter baumannii with intravenous and intrathecal colistin.
    Ho YH; Wang LS; Chao HJ; Chang KC; Su CF
    J Microbiol Immunol Infect; 2007 Dec; 40(6):537-40. PubMed ID: 18087636
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii pneumonia: experience in a tertiary care hospital in northern Taiwan.
    Lin CC; Liu TC; Kuo CF; Liu CP; Lee CM
    J Microbiol Immunol Infect; 2010 Aug; 43(4):323-31. PubMed ID: 20688293
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Variables determining mortality in patients with Acinetobacter baumannii meningitis/ventriculitis treated with intrathecal colistin.
    Ceylan B; Arslan F; Sipahi OR; Sunbul M; Ormen B; Hakyemez İN; Turunc T; Yıldız Y; Karsen H; Karagoz G; Tekin R; Hizarci B; Turhan V; Senol S; Oztoprak N; Yılmaz M; Ozdemir K; Mermer S; Kokoglu OF; Mert A
    Clin Neurol Neurosurg; 2017 Feb; 153():43-49. PubMed ID: 28013184
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Challenges to conducting a clinical trial of combination therapy of colistin and rifampicin for extensively drug-resistant Acinetobacter baumannii.
    Huang DB; Pastagia M; Chiang T
    Clin Infect Dis; 2014 Jan; 58(1):141-2. PubMed ID: 24081682
    [No Abstract]   [Full Text] [Related]  

  • 55. Successful treatment of septic shock due to pan-resistant Acinetobacter baumannii using combined antimicrobial therapy including tigecycline.
    Taccone FS; Rodriguez-Villalobos H; De Backer D; De Moor V; Deviere J; Vincent JL; Jacobs F
    Eur J Clin Microbiol Infect Dis; 2006 Apr; 25(4):257-60. PubMed ID: 16572310
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparable Efficacy of Tigecycline versus Colistin Therapy for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Pneumonia in Critically Ill Patients.
    Kim WY; Moon JY; Huh JW; Choi SH; Lim CM; Koh Y; Chong YP; Hong SB
    PLoS One; 2016; 11(3):e0150642. PubMed ID: 26934182
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacodynamics of tigecycline alone and in combination with colistin against clinical isolates of multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model.
    Cai X; Yang Z; Dai J; Chen K; Zhang L; Ni W; Wei C; Cui J
    Int J Antimicrob Agents; 2017 May; 49(5):609-616. PubMed ID: 28315729
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Nebulized colistin treatment of multi-resistant Acinetobacter baumannii pulmonary infection in critical ill patients].
    Pérez-Pedrero MJ; Sánchez-Casado M; Rodríguez-Villar S
    Med Intensiva; 2011 May; 35(4):226-31. PubMed ID: 21396739
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Real-time sequencing to decipher the molecular mechanism of resistance of a clinical pan-drug-resistant Acinetobacter baumannii isolate from Marseille, France.
    Rolain JM; Diene SM; Kempf M; Gimenez G; Robert C; Raoult D
    Antimicrob Agents Chemother; 2013 Jan; 57(1):592-6. PubMed ID: 23070160
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance.
    Qureshi ZA; Hittle LE; O'Hara JA; Rivera JI; Syed A; Shields RK; Pasculle AW; Ernst RK; Doi Y
    Clin Infect Dis; 2015 May; 60(9):1295-303. PubMed ID: 25632010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.